Biotech startup METiS Therapeutics plans Hong Kong IPO with AI-driven drug delivery revolution
By Da Cheung METiS Therapeutics, a drug discovery and delivery biotech, has received the regulatory green light…
Latest
- Yangtze Memory IPO: A blockbuster quarter, but three hurdles loom
- InnoLight rides AI infrastructure boom as China spending lags
- Spacecom raises $1 billion in record funding round to build out satellite constellation
- China’s humanoid robot boom is still a game of money as demand lags
- Didi’s domestic strength masks overseas drag
